NECTIN4 and hepatocellular carcinoma: In 87 samples with hepatocellular carcinoma higher Nectin-4 expression was associated with shorter recurrence free survival (17.73 months versus 25.79 months, p = 0.006) and median OS (21.92 months versus 31.32 months, p = 0.005) [38].